LRRK2 and Parkinson disease: Even though most familial monogenic forms of PD are identified, metabolic research mainly focuses on the minority of PD related-genes mutations, including SNCA, LRRK2, PARK2, and GBA. Therefore, a thorough understanding of these gene-related metabolomics will provide available biomarkers for diagnosing and tracking familial PD.